European Medicines Agency (EMA) has issued a Conditional Marketing Authorisation (CMA) ...

Medical Information

This medical information website is intended only for healthcare professionals in Africa. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

May 15, 2020

This medicinal product may not have a marketing authorization in your country, may have been allocated via COVAX or may have an authorization for Emergency Use only as granted by the the relevant national health regulatory authority. It is used for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals within the authorized age range. Please refer to the enclosed COVID-19 mRNA Vaccine (BNT162b2) product information (via the link or enclosed) for important treatment considerations regarding the vaccine. This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.